www.TooNiceStocks.com - Sign up for weekly Technical and Equity Research Reports covering all equity sectors. We have a proven track record, please come visit and see for yourself.
New York, NY -- (SBWIRE) -- 11/06/2012 -- Servicesource International Inc (NASDAQ:SREV) ServiceSource plummeted on early trading this morning after its financial outlook by analysts has dwindled. ServiceSource expected revenues for Q4 are below the Wall Street Estimate from $65.4million to ServiceSource's estimate between $62 and $64 million. Pushing off of the current low of day of $5.06, trading at an intraday of $5.33 (-35%) with over 5million shares traded. As the company already expects a loss in Q4 revenue, will ServiceSource beat their own expectations for Q4 even as weak economic conditions adversely affect many of its customers? Stick around.
Express Scripts Holding Company (NASDAQ:ESRX) In Express Scripts Q3 Earnings statement yesterday said per-share earnings is estimated to grow next year. Although expectations are set for next year, Express Scripts is trading at an intraday of $53.40 (-15.08%) with over 24million shares that have exchanged hands, will Express bounce back to it's previous levels over $60? Stick around.
Jive Software Inc (NASDAQ:JIVE)Jive Software announced that Bryan LeBlanc, Chief Financial OFficer, will present at: The Wells Fargo 2012 Technology, Media & Telecom Conference being held at the New York Palace in New York City on November 8, 2012 at 9:40 a.m. ET. Jive is setting a base above $13, trading at an intraday of $13.03 (+16.34%) with over 2.3million shares exchanged, can Jive Software continue with this bullish momentum or fall back towards the 52 week low? Stick around.
Myriad Genetics, Inc. (NASDAQ:MYGN)Myriad Genetics announced revenue for the first fiscal quarter that ended Sept. 30, 2012. "In what has historically been a challenging summer quarter, Myriad achieved record revenue and higher operating profits," said Peter D. Meldrum, President and Chief Executive Officer of Myriad Genetics, Inc."We believe that our initiatives of growing existing tests and markets have fueled these strong financial results and we continue to be excited about the future potential contributions from our strategic directives of expanding internationally and launching new tests across a diverse set of major disease indications." Myriad surged at the open market reaching a new 52week high of $30.27, trading at an intraday of $29.83 (+11.10%) with over 1.6million shares traded, will Myriad Genetics push further on bullish momentum and break the 52week high that it produced today? Stick around.
Responsys Inc (NASDAQ:MKTG) Responsys fell today as the company reported lower than expected Q3 Revenues. Although analysts have reduced their target price on the company, many believe the stock looks appetizing at these price levels. Trading at an intraday of $6.055 (-30.64%) with over 3.1million shares that have exchanged hands, will Responsys be able to bounce back? Stick around.
View Full NASDAQ Report: http://toonicestocks.com/news/2681-nasdaq-move-aggressively-q3-srev-esrx-jive-mygn-mktg
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestocks or like us on
Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.
None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)